<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <title>LiquidMammo™ | Breast cancer screening reimagined</title>

  <!-- SEO -->
  <meta name="description" content="LiquidMammo is a microRNA-based blood test that complements breast cancer screening, helping improve detection performance, especially in dense breasts.">

  <!-- Stylesheet -->
  assets/css/styles.css

  <!-- Favicon -->
  favicon.png
</head>

<body>

<!-- ======================================
     HEADER — LARGE LOGO + BRAND NAME
======================================= -->
<header style="background:white; border-bottom:4px solid #E91E63; padding:14px 0;">
  <div class="container" style="margin:0 auto;">
    <nav style="display:flex; align-items:center; justify-content:space-between; flex-wrap:wrap; gap:22px;">

      <div class="brand" style="display:flex; align-items:center; gap:18px;">
        assets/logos/liquidmammo-logo.png
        <strong style="font-size:2.35rem; font-weight:900; letter-spacing:-0.8px; color:#E91E63;">
          LiquidMammo™
        </strong>
      </div>

      <div class="nav-links"
           style="display:flex; flex-wrap:wrap; gap:20px; font-weight:500; color:#E91E63;">
        how-it-works.htmlHow It Works</a>
        science.htmlScience</a>
        evidence.htmlEvidence</a>
        patients.htmlPatients</a>
        clinicians.htmlClinicians</a>
        biobank.htmlBiobank</a>
        pricing.htmlPricing</a>
        contact.htmlContact</a>
        privacy.htmlPrivacy</a>
        about.htmlAbout</a>
      </div>

    </nav>
  </div>
</header>


<!-- ======================================
     HERO
======================================= -->
<section class="hero" style="padding:32px 0; text-align:center;">
  <div class="container" style="margin:0 auto; text-align:center;">

    <h1 style="font-size:2.4rem; margin-bottom:10px; font-weight:800;">
      Breast cancer screening reimagined
    </h1>

    <p class="small" style="max-width:650px; margin:0 auto 22px auto;">
      A supplemental microRNA-based blood test designed to complement breast imaging by providing biologically‑driven insight — particularly where dense tissue makes cancers harder to detect.
    </p>

    <div class="cta-row" style="justify-content:center; display:flex; gap:12px;">
      patients.html#joinJoin Early Access</a>
      clinicians.html#enrollClinician Enrollment</a>
    </div>

    <p class="notice" style="max-width:600px; margin:22px auto 0 auto;">
      LiquidMammo is being developed as a
      <strong>CLIA Laboratory Developed Test (LDT)</strong>; not yet FDA‑cleared or FDA‑approved.
    </p>
  </div>
</section>


<!-- ======================================
     WHY IT MATTERS
======================================= -->
<section class="panel-light section" style="padding:32px 0;">
  <div class="container grid-3" style="margin:0 auto; justify-items:center; text-align:center;">

    <div class="card-mini">
      <h4>Dense breasts challenge mammography</h4>
      <p class="small">
        Dense tissue can hide cancers on imaging, reducing sensitivity and increasing uncertainty.
      </p>
    </div>

    <div class="card-mini">
      <h4>Earlier biological signal</h4>
      <p class="small">
        microRNA changes can emerge before tumors become visible on mammograms.
      </p>
    </div>

    <div class="card-mini">
      <h4>More consistent screening</h4>
      <p class="small">
        A biological complement helps add confidence and consistency across diverse populations.
      </p>
    </div>

  </div>
</section>


<!-- ======================================
     CLINICAL CONTEXT (CLEARER VERSION)
======================================= -->
<section class="section" style="padding:32px 0;">
  <div class="container" style="margin:0 auto; text-align:center;">

    <h2>Clinical context</h2>

    <div class="grid-3" style="justify-items:center; text-align:center;">

      <div class="stats-card">
        <ul class="list-tight">
          <li><strong>Mammograms can miss cancers</strong>, especially in dense breast tissue.</li>
          <li>Interval cancers—those found between screenings—occur more often in dense breasts.</li>
          <li><strong>False positives are common</strong>, leading many women to undergo additional imaging over time.</li>
        </ul>
      </div>

      <div class="stats-card">
        <ul class="list-tight">
          <li>In extremely dense breasts, imaging sensitivity may fall to <strong>~61%</strong>.</li>
          <li>Younger women typically have denser breasts, making detection more difficult.</li>
          <li>Screening adherence drops when imaging alone feels uncertain or stressful.</li>
        </ul>
      </div>

      <div class="card note-card">
        <p class="small">
          LiquidMammo is designed to <strong>support—not replace—imaging</strong>. By combining molecular insight with mammography, clinicians can strengthen early detection for a wider range of patients.
        </p>
      </div>

    </div>

  </div>
</section>


<!-- ======================================
     HOW IT WORKS (PREVIEW)
======================================= -->
<section class="panel-light section" style="padding:32px 0;">
  <div class="container" style="margin:0 auto; text-align:center;">
    <h2>How it works</h2>

    <div class="grid-3" style="justify-items:center; text-align:center;">

      <div class="card-mini">
        <h4>1 — Ordered by clinician</h4>
        <p class="small">A simple blood draw performed during a routine visit.</p>
      </div>

      <div class="card-mini">
        <h4>2 — microRNA profiling</h4>
        <p class="small">A multi‑marker microRNA panel is analyzed to detect biological signals.</p>
      </div>

      <div class="card-mini">
        <h4>3 — Clinician‑ready report</h4>
        <p class="small">Results are delivered with density‑aware interpretation and screening guidance.</p>
      </div>

    </div>
  </div>
</section>


<!-- ======================================
     FOOTER
======================================= -->
<footer>
  <div class="container footer-grid" style="margin:0 auto;">

    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral, Cambridge, MA.
      </p>
    </div>

    <div class="footer-logo">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">
        Developed by<br/>MultiOmics Inc.
      </div>
    </div>

  </div>

  <div class="container footer-note" style="margin-top:14px; margin-bottom:12px; text-align:center;">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    privacy.htmlPrivacy &amp; Compliance</a> •
    contact.htmlOrder / Kits</a>
  </div>
</footer>

</body>
</html>
